Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism.

Duan Linli, Zhou Nuofu,Yan Huang, Guo Yehui,Zhang Nuofu,Hong Cheng,Yang Xinyan,Su Xiaofen,Chen Rongchang,Zhou Ying,Zhong Nanshan,Liu Chunli

Clinica Chimica Acta（2016）

引用 4|浏览61

暂无评分

摘要

•The aim was to investigate, in comparison to the standard-therapy method, the potential of rivaroxaban in treatment of patients with PE.•Sixty-two PE patients were randomized to rivaroxaban mono-therapy or standard-therapy groups.•Rivaroxaban mono-therapy result in shorter hospital stay compared to the standard-therapy.

查看译文

关键词

Pulmonary embolism,Rivaroxaban,CYP2C9,VKORC1,Deep venous thrombosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要